Welcome to the second edition of our corporate review. 2017/2018 proved to be another exciting year for the Corporate and Commercial team at Barlow Robbins with new clients and a significant new member of the team.
We begin by taking a look back at some of the deals we have advised on. As ever, Brexit has not been far from people’s minds. Perhaps surprisingly, the continued uncertainty did not lead to a fall in the level of activity in the market. As we noted last year, the continued weakness of the pound has made UK companies an attractive proposition for overseas buyers. We will have to wait and see what 2019 brings.
We are lucky, once again, to have the benefit of Professor Joe Nellis’ insight into the position and prospects of the UK economy.
We survey the options open to private companies when they want to issue shares in order to raise money.
We have continued to enjoy working with Lifelines Neurodiagnostic Systems, Inc, a company based in Illinois which makes and distributes innovative medical devices. The CEO, Simon Griffin, discusses the development of the company and its products.
Finally, we are pleased to welcome a new partner, Tim Matthews, to the team. Tim was previously a partner at a US law firm and brings a wealth of experience, particularly in the life sciences sector.
Thank you for reading.
- Corporate Highlights 2018 Deals (read article)
- Outlook for the UK Economy (read article)
- Equity Fundraising: A Guide for Private Companies (read article)
- Client Focus: Lifelines Neurodiagnostics (read article)
- In the Spotlight: Tim Matthews (read article)
For further advice on the above topics, please call us on 01483 543210 or alternatively email email@example.com